Necessity of Anti-Arrhythmic Medication After Surgical Ablation for Atrial Fibrillation
Anti-Arrhythmic Medication (Amiodarone) Post Surgical Ablation for Atrial Fibrillation - Is it Necessary?
Sponsor: Inova Health Care Services
Terminated
This trial was terminated. No reason was provided.
Other terminated trials from Inova Health Care Services
Other Atrial Fibrillation trials with similar outcome
Listed as NCT01416935, this NA trial focuses on Atrial Fibrillation and remains terminated or withdrawn. Sponsored by Inova Health Care Services, it has been updated 6 times since 2011, reflecting limited change activity. This study contributes longitudinal data to the cardiovascular research landscape.
Status Flow
Change History
6 versions recorded-
Sep 2024 — Present [monthly]
Terminated NA
-
Jul 2024 — Sep 2024 [monthly]
Terminated NA
-
Feb 2022 — Jul 2024 [monthly]
Terminated NA
Status: Unknown Status → Terminated
-
Jan 2021 — Feb 2022 [monthly]
Unknown Status NA
-
Jun 2018 — Jan 2021 [monthly]
Unknown Status NA
Status: Active Not Recruiting → Unknown Status
▶ Show 1 earlier version
-
Jan 2017 — Jun 2018 [monthly]
Active Not Recruiting NA
First recorded
Jan 2011
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Inova Health Care Services
For direct contact, visit the study record on ClinicalTrials.gov .